Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 102 results for "glenmark"

Glenmark Pharma rises 1% on USFDA nod for Aprepitant capsules
Money Control

Glenmark Pharma receives approval for generic Emend capsules

Glenmark Pharma receives approval for generic Emend capsules Source: IRIS | 16 Oct, 2017, 10.01AM Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Aprepitant Capsules ... Myiris, 4 days ago
[x]  

38 images for glenmark

Business Standard, 4 days ago
Money Control, 4 days ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Today, 4 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 2 months ago
Money Control

Glenmark's Glenn Saldanha appointed IPA President

Indian Pharmaceutical Alliance (IPA), a body of major domestic pharma firms, today said Glenn Saldanha has been appointed as President for 2017-19.Saldanha is Chairman & Managing Director of Glenmark Pharmaceuticals.IPA also appointed Panacea Biotec Joint ...
 Business Standard4 days ago Glenmark says specialty innovative products to contribute 30% revenues by 2025  Money Control3 weeks ago 30% revenue from innovative products by 2025: Glenmark Pharmaceuticals CMD  Business Standard2 months ago
Money Control

Exit Glenmark Pharma, says Ashwani Gujral

According to Ashwani Gujral of ashwanigujral.com, one may exit Glenmark Pharma.
 Money Control1 week ago Sell Glenmark Pharma; buy LT, Indraprastha Gas: Ashwani Gujral  Money Control1 month ago Buy Tata Global, HUL; sell Lupin, Sun Pharma, Glenmark Pharma: Ashwani Gujral  Money Control2 months ago Buy Can Fin Homes, Glenmark Pharma, Motherson Sumi Systems: Ashwani Gujral  Money Control2 months ago
Money Control

Glenmark Pharma gets healthier after posting robust Q1 results

Glenmark Pharmaceuticals rose 1.15% to Rs 724 at 14:10 IST on BSE after consolidated net profit surged 47.01% to Rs 333.38 crore on 19.99% rise in revenue to Rs 2363 crore in Q1 June 2017 over Q1 June 2016.
 Business Standard2 months ago Glenmark Pharmaceuticals consolidated net profit rises 47.01% in the June 2017 quarter  Business Standard2 months ago Glenmark Pharmaceuticals standalone net profit declines 47.80% in the June 2017 quarter  Business Standard2 months ago Glenmark Pharma records 47% jump in Q1 net at Rs 333 cr  Business Standard2 months ago
[x]  
Money Control

Glenmark Pharma falls 3% on weak market; Nomura maintains buy call

It said that it expects competition for gNitrosat to remain limited and sees a few more limited competition launches in the near term.
 Money Control3 weeks ago
Money Today

Glenmark expects generics to drive growth over next 3-4 years

Focus in emerging markets will be to invest in product pipeline in dermatology, respiratory, oncology therapy
 Business Standard3 weeks ago Glenmark charts out new path for growth  Money Today4 weeks ago
Money Control

Glenmark looks to file up to 25 product applications annually

While acknowledging strict regulatory environment, he added that the company#39;s pipeline of specialty products, to be rolled out over the next 3-4 years, is expected to act as a defence against generic price erosion and increase in competition, and boost ...
 Money Control1 month ago

Glenmark Pharma releases investigational skin findings

Drug major Glenmark Pharmaceuticals today came out with positive findings from phase 2a study of GBR 830, an investigational monoclonal anti-body in atopic dermatitis (AD), a chronic skin disease.
 DNA2 months ago Cash from out-licensing GBR 830 will be used for repayment of debt: Glenmark  Money Control2 months ago Glenmark Pharmaceuticals provides update on Phase 2a study of GBR 830  Business Standard2 months ago Glenmark reports positive data in Phase 2a study of 'GBR 830'  Myiris2 months ago
Money Control

Staying with winners! Nearly 20 FO stocks rose 10-44 percent in August series

The highest rollover was observed in Strides Shasun (84 percent), followed by DHFL (81 percent), Glenmark Pharma (80 percent), Castrol India (80 percent), JSW Energy (79 percent) etc. among others.
 Money Control1 month ago
Money Control

Buy Glenmark Pharmaceuticals; target of Rs 840: Axis Direct

Axis Direct is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 840 in its research report dated August 02, 2017.
 Money Control2 months ago Hold Glenmark Pharmaceuticals; target of Rs 670: Edelweiss  Money Control2 months ago Buy Glenmark Pharma; target of Rs 900: Reliance Securities  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less